+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Conatus Pharmaceuticals - logo

Conatus Pharmaceuticals is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. Its lead compound, emricasan, is a first-in-class, orally active pan-caspase protease inhibitor designed to reduce the activity of human caspases. In December 2016, Conatus announced an exclusive option, collaboration and license agreement with Novartis for the global development and commercialization of emricasan. The company was founded in 2005 and is headquartered in San Diego, California.

From
Fatty Liver Disease Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Fatty Liver Disease Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • August 2017
  • 335 Pages
From
From
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2020 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
From
From
Hepatocellular Carcinoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • May 2018
  • 1275 Pages
From
Cirrhosis - Pipeline Insight, 2020 - Product Thumbnail Image

Cirrhosis - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Polycystic Kidney Disease - Pipeline Insight, 2020 - Product Thumbnail Image

Polycystic Kidney Disease - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
From
From
Hepatocellular Carcinoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H2 2017

  • Drug Pipelines
  • November 2017
  • 1120 Pages
From
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017

  • Drug Pipelines
  • February 2017
  • 402 Pages
From
From
From
From
Portal Hypertension Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Portal Hypertension Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • May 2018
  • 106 Pages
From
Loading Indicator
adroll